Ebos Group
EBOS Group Ltd is a Australasian healthcare and animal care wholesale distribution enterprise operating across Australia and New Zealand. The company distributes pharmaceutical medicines, medical consumables, hospital equipment, consumer healthcare products, pet food, and veterinary supplies under brands including Symbion, ProPet, and Black Hawk. Main revenue drivers consist of wholesale distribution margins on pharmaceutical supplies, hospital medical device sales, contract logistics charges, and retail sales of premium pet care products. EBOS Group serves community prescription pharmacies, hospital networks, aged care facilities, veterinary clinics, and pet owners across Australia and New Zealand. The enterprise holds a market-leading dominant position in Australasia for pharmaceutical wholesaling and medical device distribution. Headquartered in Christchurch, New Zealand, and Melbourne, Australia, EBOS Group Ltd is listed on the New Zealand Exchange and Australian Securities Exchange.
3 of the funds FundTelligence covers report a position in Ebos Group.
- Legal name
- Ebos Group Ltd
- Sector
- Health Care
- Country
- New Zealand
- Funds holding it
- 3
Funds holding Ebos Group
- DNB Global Enhanced Small Cap — DNB · 0.03 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.02 % (partially disclosed portfolio, June 2026)
- Handelsbanken Utviklede Markeder Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, October 2026)